CAS ID: | 1413431-07-8 |
Molecular Formula: | C24H28N2O3 |
Molecular Weight: | 401.6 g/mol |
Monoisotopic Mass: | 401.266 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | |
Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
ClinicalTrial ID | NCT02951182 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | November 1, 2016 | Last Verified | August 15, 2018 |
Sponsor | Vertex Pharmaceuticals Incorporated |
Trial Record 2
ClinicalTrial ID | NCT02971839 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Terminated |
First Received | November 23, 2016 | Last Verified | August 15, 2018 |
Sponsor | Vertex Pharmaceuticals Incorporated |
PubChem: | 71470491 |
ChEMBL: |